首页> 外文期刊>Cancer Medicine >LncRNA H19 interacted with miR‐130a‐3p and miR‐17‐5p to modify radio‐resistance and chemo‐sensitivity of cardiac carcinoma cells
【24h】

LncRNA H19 interacted with miR‐130a‐3p and miR‐17‐5p to modify radio‐resistance and chemo‐sensitivity of cardiac carcinoma cells

机译:LncRNA H19与miR‐130a‐3p和miR‐17‐5p相互作用以修饰心脏癌细胞的放射抗性和化学敏感性

获取原文
           

摘要

The current investigation explored the synthetic contribution of lncRNA H19, miR‐130a‐3p, and miR‐17‐5p to radio‐resistance and chemo‐sensitivity of cardiac cancer cells. Totally 284 human cardiac cancer tissues were gathered, and they have been pathologically diagnosed. The cardiac cancer cells were isolated with utilization of the mechanic method. Moreover, cisplatin, adriamycin, mitomycin, and 5‐fluorouracil were designated as the chemotherapies, and single‐dose X‐rays were managed as the radiotherapy for cardiac cancer cells. We also performed luciferase reporter gene assay to verify the targeted relationship between H19 and miR‐130a‐3p, as well as between H19 and miR‐17‐5p. Finally, mice models were established to examine the functions of H19, miR‐130a‐3p, and miR‐17‐5p on the development of cardiac cancer. The study results indicated that H19, miR‐130a‐3p, and miR‐17‐5p expressions within cardiac cancer tissues were significantly beyond those within adjacent nontumor tissues ( P ??0.05), and H19 expression was positively correlated with both miR‐130a‐3p ( r s ?=?0.43) and miR‐17‐5p ( r s ?=?0.49) expressions. The half maximal inhibitory concentrations (IC50) of cisplatin, adriamycin, mitomycin, and 5‐fluorouracil for cardiac cancer cells were, respectively, determined as 2.01?μg/mL, 8.35?μg/mL, 24.44?μg/mL, and 166.42?μg/mL. The overexpressed H19, miR‐130a‐3p, and miR‐17‐5p appeared to improve the survival rate and viability of cardiac cancer cells that were exposed to chemotherapies and X‐rays (all P ??0.05). It was also drawn from luciferase reporter gene assay that H19 could directly target miR‐130a‐3p and miR‐17‐5p, thereby modifying the sensitivity of cardiac cancer cells to drugs and X‐rays ( P ??0.05). Finally, the mice models also produced larger tumor size and higher tumor weight, when H19, miR‐130a‐3p, or miR‐17‐5p expressions were up‐regulated within them ( P ??0.05). In conclusion, H19 could act on miR‐130a‐3p or miR‐17‐5p to alter the radio‐ and chemo‐sensitivities of cardiac cancer cells, helping to improve the radio‐/chemotherapies for cardiac cancer.
机译:当前的研究探索了lncRNA H19,miR-130a-3p和miR-17-5p对心脏癌细胞的放射抵抗和化学敏感性的合成作用。总共收集了284个人类心脏癌组织,并对其进行了病理诊断。利用力学方法分离出cancer门癌细胞。此外,顺铂,阿霉素,丝裂霉素和5-氟尿嘧啶被指定为化学疗法,单剂量X射线被作为心脏癌细胞的放射疗法。我们还进行了萤光素酶报告基因检测,以验证H19与miR‐130a-3p之间以及H19与miR‐17-5p之间的靶向关系。最后,建立了小鼠模型以检查H19,miR-130a-3p和miR-17-5p对心脏癌的作用。研究结果表明,cardiac门癌组织中的H19,miR‐130a‐3p和miR‐17‐5p表达明显高于相邻的非肿瘤组织中的表达(P <0.05),并且H19与这两种miR呈正相关。 130a-3p(rs == 0.43)和miR-17-5p(rs == 0.49)表达式。顺铂,阿霉素,丝裂霉素和5-氟尿嘧啶对心脏癌细胞的最大半数抑制浓度(IC50)分别为2.01?μg/ mL,8.35?μg/ mL,24.44?μg/ mL和166.42?微克/毫升过度表达的H19,miR-130a-3p和miR-17-5p似乎可以提高暴露于化学疗法和X射线的cardiac门癌细胞的存活率和生存力(所有P≤0.05)。从萤光素酶报告基因分析还得出结论,H19可以直接靶向miR-130a-3p和miR-17-5p,从而改变心脏癌细胞对药物和X射线的敏感性(P <0.05)。最后,当小鼠模型中的H19,miR-130a-3p或miR-17-5p表达上调时,它们也会产生更大的肿瘤大小和更大的肿瘤重量(P 0.05)。总之,H19可以对miR-130a-3p或miR-17-5p起作用,以改变心脏癌细胞的放射敏感性和化学敏感性,从而有助于改善心脏的放射/化学疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号